Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pur...
Innovation starts from the heart. Heart valve disease affects millions of people worldwide — across all ages, backgrounds, and geographies. As communities globally navigate the opportunities and chal...
Innovation starts from the heart. Heart valve disease affects millions of people worldwide — across all ages, backgrounds, and geographies. As communities globally navigate the opportunities and chal...
Innovation starts from the heart. Heart valve disease affects millions of people worldwide — across all ages, backgrounds, and geographies. As communities globally navigate the opportunities and chal...
Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pur...
Innovation starts from the heart. Heart valve disease affects millions of people worldwide — across all ages, backgrounds, and geographies. As communities globally navigate the opportunities and chal...